It's easy to think of litigation finance as a single, undifferentiated pool of capital waiting to evaluate any meritorious claim. In practice, reading the publicly stated investment criteria of dozens of active funders shows a market that has sorted itself into fairly distinct tiers and specialties, and approaching the wrong tier is one of the more common ways claimants and counsel waste time chasing funding that was never going to fit.
Size segmentation is the sharpest line. At the top, a handful of funders effectively won't look at anything below eight or nine figures, Innsworth states a minimum claim size around $100 million, Woodsford has moved to a £5 million floor with no ceiling, and Harbour treats claims above roughly £10 million as its standard territory. Below that sits a broad band of institutional generalists, firms like Burford Capital, Omni Bridgeway, GLS Capital, Longford Capital, and Arcadia Finance, whose single-case investments typically run from roughly $1 million to $25 million or more, tracking to underlying claims worth many multiples of that. Beneath those sits a real middle-market tier built specifically for the gap the larger funders' economics don't support: Statera Capital (a stated $500,000-$4 million range), Validity Finance (roughly $2-4 million per case), and Orchard Global's deliberate focus on cases with $1-3 million budgets. Below roughly $250,000, only a small number of marketplace or algorithmically driven funders, such as Legalist and LexShares, will typically engage at all.
Practice-area specialization runs deeper than most directories suggest. Soryn IP Group and much of 1624's book are patent and intellectual-property financing only. Deminor has built particular depth in securities and shareholder claims. Delta Capital Partners Management is structured specifically around judgment enforcement and asset recovery, collecting on claims already won, not funding new litigation. Augusta Ventures has a distinct concentration in construction, energy, and infrastructure disputes. And personal injury and mass tort sit almost entirely outside the commercial funding market: Omni Bridgeway, Validity Finance, Curiam Capital, Harbour, and Balance Legal Capital all explicitly exclude individual personal injury claims from what they'll consider, leaving that category to a much smaller set of specialists, such as Pravati Capital, built around it deliberately.
The practical implication is straightforward: before approaching any specific funder, it's worth understanding roughly where a matter's claim size and case type sit within this landscape. A $2 million commercial contract dispute is a realistic fit for a middle-market specialist and a near-certain pass for a funder whose stated floor is $100 million, not because the case lacks merit, but because it never matched that funder's economics in the first place. The Institute's financier directory lists publicly stated investment criteria for each of the funders discussed here, and the AI Concierge can walk through how a specific matter's characteristics compare against the market.